Sengupta SK - Search Results

1

Malignant phyllodes tumor with liposarcomatous differentiation.

Isotalo PA, George RL, Walker R, Sengupta SK. Isotalo PA, et al. Among authors: sengupta sk. Arch Pathol Lab Med. 2005 Mar;129(3):421-2. doi: 10.5858/2005-129-421-MPTWLD. Arch Pathol Lab Med. 2005. PMID: 15737047 Free article. No abstract available.

2

Primary basaloid carcinoma of the nipple with associated squamous cell carcinoma in situ.

Chen CH, Rowlands C, Sengupta SK, George RL, Parulekar W, Thain K, O'Malley F, Isotalo PA. Chen CH, et al. Among authors: sengupta sk. Breast J. 2009 Jul-Aug;15(4):409-13. doi: 10.1111/j.1524-4741.2009.00746.x. Breast J. 2009. PMID: 19601946

3

Laparoscopic excision of a large extra-adrenal perirenal myelolipoma.

Beiko D, Roldan H, Sengupta SK, George RL. Beiko D, et al. Among authors: sengupta sk. Can Urol Assoc J. 2010 Apr;4(2):E39-41. doi: 10.5489/cuaj.824. Can Urol Assoc J. 2010. PMID: 20368880 Free PMC article.

4

Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline.

Brackstone M, Baldassarre FG, Perera FE, Cil T, Chavez Mac Gregor M, Dayes IS, Engel J, Horton JK, King TA, Kornecki A, George R, SenGupta SK, Spears PA, Eisen AF. Brackstone M, et al. Among authors: sengupta sk. J Clin Oncol. 2021 Sep 20;39(27):3056-3082. doi: 10.1200/JCO.21.00934. Epub 2021 Jul 19. J Clin Oncol. 2021. PMID: 34279999

5

A systematic review of axillary nodal irradiation for the management of the axilla in patients with early-stage breast cancer.

Perera F, Baldassarre FG, Eisen AF, Dayes I, Engel J, Cil T, Kornecki A, George R, SenGupta S, Brackstone M. Perera F, et al. Surg Oncol. 2022 Jun;42:101754. doi: 10.1016/j.suronc.2022.101754. Epub 2022 May 2. Surg Oncol. 2022. PMID: 35550974 Review.

6

Endophilin A2 Promotes TNBC Cell Invasion and Tumor Metastasis.

Baldassarre T, Watt K, Truesdell P, Meens J, Schneider MM, Sengupta SK, Craig AW. Baldassarre T, et al. Among authors: sengupta sk. Mol Cancer Res. 2015 Jun;13(6):1044-55. doi: 10.1158/1541-7786.MCR-14-0573. Epub 2015 Mar 17. Mol Cancer Res. 2015. PMID: 25784716

7

The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells.

Elliott BE, Meens JA, SenGupta SK, Louvard D, Arpin M. Elliott BE, et al. Among authors: sengupta sk. Breast Cancer Res. 2005;7(3):R365-73. doi: 10.1186/bcr1006. Epub 2005 Mar 21. Breast Cancer Res. 2005. PMID: 15987432 Free PMC article.

8

Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer.

Ghaffari A, Hoskin V, Turashvili G, Varma S, Mewburn J, Mullins G, Greer PA, Kiefer F, Day AG, Madarnas Y, SenGupta S, Elliott BE. Ghaffari A, et al. Breast Cancer Res. 2019 Jan 24;21(1):12. doi: 10.1186/s13058-018-1079-7. Breast Cancer Res. 2019. PMID: 30678714 Free PMC article.

9

Macromolecular interstitial clearance, tumour vascularity, other prognostic factors and breast cancer survival.

Sterns EE, SenGupta S, Zee B. Sterns EE, et al. Breast Cancer Res Treat. 1997 Jan;42(2):113-20. doi: 10.1023/a:1005749825449. Breast Cancer Res Treat. 1997. PMID: 9138600

10

Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada).

Woolcott CG, Aronson KJ, Hanna WM, SenGupta SK, McCready DR, Sterns EE, Miller AB. Woolcott CG, et al. Among authors: sengupta sk. Cancer Causes Control. 2001 Jun;12(5):395-404. doi: 10.1023/a:1011289905751. Cancer Causes Control. 2001. PMID: 11545454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

175 results

Search Page